# Hematopoiesis Training Grant

> **NIH NIH T32** · UNIVERSITY OF PENNSYLVANIA · 2021 · $399,803

## Abstract

ABSTRACT
The Hematopoiesis Training Grant at the University of Pennsylvania was founded in 1999 with the primary goal
to prepare graduate students and postdoctoral fellows for careers as successful investigators working in areas
related to hematopoiesis and blood disorders. The Program has trained 30 post-doctoral and 18 pre-doctoral
scientists, including 3 post-doctoral and 4 pre-doctoral trainees currently in training. It is a multi-disciplinary,
cross-departmental training program that capitalizes on the extensive resources of the Penn School of Medicine
(PSOM), the Children’s Hospital of Philadelphia (CHOP), and School of Veterinary Medicine. The Program draws
pre-doctoral candidates from the large and highly regarded PhD and MD-PhD programs at the PSOM and post-
doctoral applicants from the competitive hematology and pathology fellowship programs at PSOM and CHOP,
and from leading laboratories in the basic science departments at Penn. Research mentorship is provided by 30
scientifically diverse trainers of all academic ranks with research interests that encompass virtually all areas of
hematopoiesis as well as young faculty who bring in cutting-edge technology to hematology research. The
academic elements of the Program include an integrated curriculum of coursework, seminars, laboratory work,
skills training, formal and informal mentoring and career counseling, presentation, and manuscript and grant
writing, which are effectively combined to train new investigators in the fundamentals of hematopoiesis. Trainees
are evaluated on the basis of written and oral presentations, Individualized Development Plans, and status
conferences with the PI/PD and both research and Program mentors. The success of this comprehensive
approach is indicated by the 100% graduation rate with first-author papers, the large numbers of predoctoral
appointees continuing in postdoctoral research, the number who have been awarded funding following Program
graduation, the number of trainee publications directly related to their T32 supported research (postdoctoral
alumni averaged 4.3 peer-reviewed papers and predoctoral alumni 3.6 papers), and the number of postdoctoral
appointees who have progressed to leadership positions in academia (56%) and industry (32%). The
Hematopoiesis Program underwent a change in leadership in December 2017. The new PI/PD is well supported
by the experienced Oversight Committees, including an Internal Advisory Board (IAB) and a new External
Advisory Board (EAB). A comprehensive review by the PI, IAB and EAB in the inaugural T32 retreat resulted in
the recommendation to increase the interactions among the trainees/mentors by establishing annual retreat and
quarterly research seminars and instituting mentor training for all ranks. The review also identified a large pool
of highly qualified pre-doctoral MD-PhD students at Penn with career interests in hematopoiesis, as well as a
continuous influx of faculty in hematopoiesis-focused research to P...

## Key facts

- **NIH application ID:** 10200768
- **Project number:** 5T32DK007780-22
- **Recipient organization:** UNIVERSITY OF PENNSYLVANIA
- **Principal Investigator:** Wei Tong
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $399,803
- **Award type:** 5
- **Project period:** 1999-07-01 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10200768

## Citation

> US National Institutes of Health, RePORTER application 10200768, Hematopoiesis Training Grant (5T32DK007780-22). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10200768. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*